文献速递艾滋病与性传播感染新发突发、热带与寄生虫病

中度覆盖下的性别中立HPV疫苗接种可根除致癌型HPV

Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied.
PubMed 文献 · J Infect Dis · 2020-01-01

芬兰社区随机试验将33个社区分为性别中立HPV16/18疫苗组、仅女孩HPV16/18疫苗组和乙肝疫苗对照组,评估18.5岁女孩的疫苗效力、 herd effect和protective effectiveness,并结合数学模型预测根除。结果显示性别中立策略对HPV18/31/33的herd effect和protective effectiveness显著更强,75%覆盖率下预测20年内根除HPV18/31/33,且仅性别中立策略可根除HPV16。

要点

  • 性别中立HPV疫苗接种策略在根除致癌型HPV上优于仅女孩接种策略。
  • 75%覆盖率下,性别中立策略预测20年内根除HPV18/31/33并最终根除HPV16。
  • 仅女孩接种策略下,即使90%以上覆盖率也难以实现根除。

核心结论

  • 性别中立HPV疫苗接种是根除致癌型HPV的更优策略。

研究设计与样本

  • 芬兰33个社区随机分为性别中立HPV16/18疫苗组、仅女孩HPV16/18疫苗组和乙肝疫苗对照组。
  • 1992-1995年出生队列中,20 513名男孩和40 852名女孩中11 662名同意参与。
  • 2010-2014年对18.5岁女孩的宫颈阴道样本进行HPV分型检测。
  • 结合数学模型扩展社区随机试验结果评估HPV根除。

主要发现

  • 在1995年出生队列中,性别中立组对HPV18/31/33的herd effect和protective effectiveness显著,且比仅女孩组分别强150%和40%。
  • 预测75%覆盖率的性别中立接种可在20年内于青少年/年轻成人中根除HPV18/31/33。
  • 75%覆盖率下,仅性别中立策略预测最终可根除HPV16。

关键数值与推荐

  • 疫苗效力、herd effect和protective effectiveness针对HPV6/11/16/18/31/33/35/39/45/51/52/56/58/59/66/68型评估。
  • 性别中立组对HPV18/31/33的herd effect和protective effectiveness比仅女孩组强150%和40%。
  • 75%覆盖率下性别中立策略预测20年内根除HPV18/31/33。

临床怎么用

  • 推荐采用性别中立HPV疫苗接种策略以提高根除致癌型HPV的可能性。
  • 中度覆盖率(如75%)下性别中立策略即可预测根除部分致癌型HPV。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Human papillomavirus (HPV) vaccination of girls with very high (>90%) coverage has the potential to eradicate oncogenic HPVs, but such high coverage is hard to achieve. However, the herd effect (HE) depends both on the HPV type and the vaccination strategy. METHODS: We randomized 33 Finnish communities into gender-neutral HPV16/18 vaccination, girls-only HPV16/18 vaccination, and hepatitis B virus vaccination arms. In 2007-2010, 11 662 of 20 513 of 40 852 of 39 420 resident boys/girls from 1992 to 1995 birth cohorts consented. In 2010-2014, cervicovaginal samples from vaccinated and unvaccinated girls at age 18.5 years were typed for HPV6/11/16/18/31/33/35/39/45/51/52/56/58/59/66/68. Vaccine efficacy for vaccinated girls, HE for unvaccinated girls, and the protective effectiveness (PE) for all girls were estimated. We extended the community-randomized trial results about vaccination strategy with mathematical modeling to assess HPV eradication. RESULTS: The HE and PE estimates in the 1995 birth cohort for HPV18/31/33 were significant in the gender-neutral arm and 150% and 40% stronger than in the girls-only arm. Concordantly, HPV18/31/33 eradication was already predicted in adolescents/young adults in 20 years with 75% coverage of gender-neutral vaccination. With the 75% coverage, eventual HPV16 eradication was also predicted, but only with the gender-neutral strategy. CONCLUSIONS: Gender-neutral vaccination is superior for eradication of oncogenic HPVs.

来源:J Infect Dis,查看原文。版权归原作者所有。

引用

  1. Vänskä S, Luostarinen T, Baussano I, et al. Vaccination With Moderate Coverage Eradicates Oncogenic Human Papillomaviruses If a Gender-Neutral Strategy Is Applied. J Infect Dis. 2020. PMID: 32161969. doi:10.1093/infdis/jiaa099

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。